BioMérieux to Distribute AdvanDx's Bacteria Dx in the US | GenomeWeb
NEW YORK (GenomeWeb News) — BioMérieux will exclusively distribute AdvanDx’s diagnostic tests in the US, the French company said Tuesday. 
 
The tests, which use in situ hybridization technology, may be used to identify Staphylococcus aureus, Candida albicans, Enterococcus faecalis and other species of bacteria in fewer than five hours, the companies said.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.